Potential benefits of supplementation with auraptene in cystic fibrosis.
Sahebkar
Amirhossein
A
D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D002957:Citrus / Q000737:chemistry; D003374:Coumarins / Q000737:chemistry* / Q000494:pharmacology*; D003550:Cystic Fibrosis / Q000188:drug therapy*; D006801:Humans; D047492:Peroxisome Proliferator-Activated Receptors / Q000378:metabolism
C436726:5-hydroxy-6-methoxy-7-(3-methyl-but-2-enyloxy)-2H-1-benzopyran-2-one; D000893:Anti-Inflammatory Agents; D003374:Coumarins; D047492:Peroxisome Proliferator-Activated Receptors; C105832:aurapten